[Combined antitumor therapy with polyamine biosynthesis inhibitors and mitomycin C]. 1983

S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi

A combined effect of the polyamine biosynthesis inhibitors, alpha-difluoromethylornithine (DFMO) and methyglyoxal-bis-guanylhydrazone (MGBG) with mitomycin C (MMC) was studied. DFMO, MGBG and MMC were given intraperitoneally to nude mice xenotransplanted human gastric cancer. This new combination of the three drugs resulted in the complete halt of the xenotransplanted tumor growth and marked decline of spermine levels in the tumor tissues. The other treatments with DFMO and MGBG as well as MMC alone were inferior to this new combined therapy in suppression in both tumor growth and tissue spermine level. These data suggest that this new combined treatment be effective against human gastric cancer.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008935 Mitoguazone Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase. Methylglyoxal Bis(guanylhydrazone),MGBG,Methyl-gag,NSC-32946,Methyl gag,Methylgag,NSC 32946,NSC32946
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009952 Ornithine An amino acid produced in the urea cycle by the splitting off of urea from arginine. 2,5-Diaminopentanoic Acid,Ornithine Dihydrochloride, (L)-Isomer,Ornithine Hydrochloride, (D)-Isomer,Ornithine Hydrochloride, (DL)-Isomer,Ornithine Hydrochloride, (L)-Isomer,Ornithine Monoacetate, (L)-Isomer,Ornithine Monohydrobromide, (L)-Isomer,Ornithine Monohydrochloride, (D)-Isomer,Ornithine Monohydrochloride, (DL)-Isomer,Ornithine Phosphate (1:1), (L)-Isomer,Ornithine Sulfate (1:1), (L)-Isomer,Ornithine, (D)-Isomer,Ornithine, (DL)-Isomer,Ornithine, (L)-Isomer,2,5 Diaminopentanoic Acid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000518 Eflornithine An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway. Difluoromethylornithine,alpha-Difluoromethylornithine,DL-alpha-Difluoromethylornithine,Eflornithine Hydrochloride,Eflornithine Monohydrochloride, Monohydrate,MDL-71,782 A,Ornidyl,RMI 71782,Vaniqa,alpha-Difluoromethyl Ornithine,DL alpha Difluoromethylornithine,MDL 71,782 A,MDL71,782 A,Ornithine, alpha-Difluoromethyl,alpha Difluoromethyl Ornithine,alpha Difluoromethylornithine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm

Related Publications

S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi
July 1990, International journal of radiation oncology, biology, physics,
S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi
October 1962, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi
January 1984, Progress in experimental tumor research,
S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi
May 1971, Rinsho hoshasen. Clinical radiography,
S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi
November 1962, Bollettino chimico farmaceutico,
S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi
January 1981, Seikagaku. The Journal of Japanese Biochemical Society,
S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi
October 1996, Journal of cataract and refractive surgery,
S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi
September 1997, Ophthalmic surgery and lasers,
S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi
August 1985, Onkologie,
S Fujimoto, and R D Shrestha, and M Miyazaki, and Y Ohyama, and F Endoh, and T Shimura, and O Takahashi, and H Sugasawa, and K Okui, and K Igarashi
February 1999, Ophthalmology,
Copied contents to your clipboard!